• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Press

In the media

Home > Press

In the media

filters

Type & Disease
Topic
Location
Date Range
Type & Disease

By Type

news type

By Disease

diseases

Topic

By Topic

topic type

Location

By Location

location-news

Date Range

By Year

date range filter – slider
1999 — 2025

Results

No results found. Please try using different filter option(s).

Healthcare worker attending a training
Press Releases Translations
10 Jul 2025

Un nouveau projet en RDC vise à améliorer l’accès aux soins des personnes atteintes de la maladie à VIH à un stade avancé

Healthcare worker attending a training
Press releases
10 Jul 2025

New HIV project in the DRC brings life-saving care closer to people with advanced HIV disease

Woman working in a laboratory
News
10 Jul 2025

LEO Foundation partners with DNDi to develop breakthrough drug discovery model for mycetoma 

In the media
4 Jul 2025

New drug to be registered with FDA

Bangkok Post
Press releases
1 Jul 2025

Thailand’s Government Pharmaceutical Organization (GPO) partners with DNDi and Pharco to register an effective and affordable hepatitis C treatment  

Young boy in front of a house in rural village
Publications
27 Jun 2025

2024 DNDi Financial Report

In the media
26 Jun 2025

¿Qué es la enfermedad de chagas? Habla hombre que resucitó tras padecerla

Los Informantes
Scientific articles
26 Jun 2025

Validated LC-MS/MS method for quantifying the antiparasitic nitroimidazole DNDI-0690 in preclinical target site PK/PD studies

Biomedical Chromatography
Nature logo
In the media
25 Jun 2025

First all-oral treatment for deadly strain of sleeping sickness now available in Africa

Nature
BMJ Innovations logo
In the media
17 Jun 2025

Can the use of AI in the pharmaceutical sector deliver new medicines, not new risks?

BMJ Innovations
In the media
17 Jun 2025

Serum Institute signs MoU with DNDi to develop dengue treatment candidate

Business Standard
In the media
17 Jun 2025

‘Timely’ alliance to develop effective dengue treatment

The Sun
ET Pharma logo
In the media
14 Jun 2025

Serum Institute to conduct Brazilian trials of late-stage dengue candidate with DNDi

ET Pharma
In the media
14 Jun 2025

Serum, DNDi to develop affordable dengue treatment

Hindustan Times
The Hindu logo
In the media
14 Jun 2025

SII, DNDi partner for expanding human trials for dengue treatment

The Hindu
Press Trust of India logo
In the media
13 Jun 2025

Serum, DNDi join hands to fast-track development of new treatment for dengue

Press Trust of India
loading
Loading...
In the media
4 Jul 2025

New drug to be registered with FDA

Bangkok Post
In the media
26 Jun 2025

¿Qué es la enfermedad de chagas? Habla hombre que resucitó tras padecerla

Los Informantes
Nature logo
In the media
25 Jun 2025

First all-oral treatment for deadly strain of sleeping sickness now available in Africa

Nature
In the media
17 Jun 2025

‘Timely’ alliance to develop effective dengue treatment

The Sun
In the media
17 Jun 2025

Serum Institute signs MoU with DNDi to develop dengue treatment candidate

Business Standard
BMJ Innovations logo
In the media
17 Jun 2025

Can the use of AI in the pharmaceutical sector deliver new medicines, not new risks?

BMJ Innovations
The Hindu logo
In the media
14 Jun 2025

SII, DNDi partner for expanding human trials for dengue treatment

The Hindu
In the media
14 Jun 2025

Serum, DNDi to develop affordable dengue treatment

Hindustan Times
ET Pharma logo
In the media
14 Jun 2025

Serum Institute to conduct Brazilian trials of late-stage dengue candidate with DNDi

ET Pharma
Press Trust of India logo
In the media
13 Jun 2025

Serum, DNDi join hands to fast-track development of new treatment for dengue

Press Trust of India
France 24 logo
In the media
10 Jun 2025

Sudanese doctors on mission to rebuild Mycetoma Research Centre

France 24
TV5Monde-logo
In the media
8 Jun 2025

Kenya: le mycétome, une maladie endémique pourtant encore négligée

TV5Monde
In the media
8 Jun 2025

Uncovering Turkana’s Silent Plague: The Gruesome Disease Crippling a Region

The Kenyan Historian
Nikkei
In the media
6 Jun 2025

数奇な運命でスーダンに エーザイ発の新薬候補、熱帯病に挑む

Nikkei
El Pais logo
In the media
3 Jun 2025

El acuerdo sobre pandemias es nuestra oportunidad de priorizar a las personas

El País
EFE logo
In the media
27 May 2025

La OMS adopta un plan para afrontar las enfermedades sensibles al cambio climático

EFE
1 2 … 124 ›

Connect and share

Follow us on social media to stay updated and help us share the stories of neglected patients.  

Twitter Facebook Instagram Youtube Linkedin
EN ESPAÑOL
EM PORTUGUÊS
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License